341 related articles for article (PubMed ID: 35807415)
1. Application of Mathematical Modeling and Computational Tools in the Modern Drug Design and Development Process.
Hasan MR; Alsaiari AA; Fakhurji BZ; Molla MHR; Asseri AH; Sumon MAA; Park MN; Ahammad F; Kim B
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807415
[TBL] [Abstract][Full Text] [Related]
2. Application of
Haider M; Chauhan A; Tariq S; Pathak DP; Siddiqui N; Ali S; Pottoo FH; Ali R
Curr Top Med Chem; 2021; 21(11):995-1011. PubMed ID: 34061002
[TBL] [Abstract][Full Text] [Related]
3. Modern Computational Strategies for Designing Drugs to Curb Human Diseases: A Prospect.
Dar KB; Bhat AH; Amin S; Hamid R; Anees S; Anjum S; Reshi BA; Zargar MA; Masood A; Ganie SA
Curr Top Med Chem; 2018; 18(31):2702-2719. PubMed ID: 30659543
[TBL] [Abstract][Full Text] [Related]
4. Advances in Drug Discovery and Design using Computer-aided Molecular Modeling.
Singh K; Bhushan B; Singh B
Curr Comput Aided Drug Des; 2024; 20(5):697-710. PubMed ID: 37711101
[TBL] [Abstract][Full Text] [Related]
5. Recent Trends in Computer-aided Drug Design for Anti-cancer Drug Discovery.
Razia IT; Kanwal A; Riaz HF; Malik A; Ahsan M; Khan MS; Raza A; Sabir S; Sajid Z; Khan MF; Tahir RA; Sehgal SA
Curr Top Med Chem; 2023; 23(30):2844-2862. PubMed ID: 38031798
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
[TBL] [Abstract][Full Text] [Related]
7. The role and potential of computer-aided drug discovery strategies in the discovery of novel antimicrobials.
Oselusi SO; Dube P; Odugbemi AI; Akinyede KA; Ilori TL; Egieyeh E; Sibuyi NR; Meyer M; Madiehe AM; Wyckoff GJ; Egieyeh SA
Comput Biol Med; 2024 Feb; 169():107927. PubMed ID: 38184864
[TBL] [Abstract][Full Text] [Related]
8. Computer Aided Drug Design for Multi-Target Drug Design: SAR /QSAR, Molecular Docking and Pharmacophore Methods.
Abdolmaleki A; Ghasemi JB; Ghasemi F
Curr Drug Targets; 2017; 18(5):556-575. PubMed ID: 26721410
[TBL] [Abstract][Full Text] [Related]
9. Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models.
Zaka M; Abbasi BH; Durdagi S
J Biomol Struct Dyn; 2019 Jun; 37(9):2464-2476. PubMed ID: 30047845
[TBL] [Abstract][Full Text] [Related]
10. Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies.
Mirza SB; Lee RCH; Chu JJH; Salmas RE; Mavromoustakos T; Durdagi S
J Mol Graph Model; 2018 Jan; 79():88-102. PubMed ID: 29156382
[TBL] [Abstract][Full Text] [Related]
11. An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19.
Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM
Biomed Res Int; 2021; 2021():8853056. PubMed ID: 34258282
[TBL] [Abstract][Full Text] [Related]
12. Systematic generation of chemical structures for rational drug design based on QSAR models.
Funatsu K; Miyao T; Arakawa M
Curr Comput Aided Drug Des; 2011 Mar; 7(1):1-9. PubMed ID: 20550510
[TBL] [Abstract][Full Text] [Related]
13. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
14. Role of computer-aided drug design in modern drug discovery.
Macalino SJ; Gosu V; Hong S; Choi S
Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
[TBL] [Abstract][Full Text] [Related]
15. Proposing novel TNFα direct inhibitor Scaffolds using fragment-docking based e-pharmacophore modeling and binary QSAR-based virtual screening protocols pipeline.
Zaka M; Abbasi BH; Durdagi S
J Mol Graph Model; 2018 Oct; 85():111-121. PubMed ID: 30149308
[TBL] [Abstract][Full Text] [Related]
16. Computer Aided Drug Design and its Application to the Development of Potential Drugs for Neurodegenerative Disorders.
Baig MH; Ahmad K; Rabbani G; Danishuddin M; Choi I
Curr Neuropharmacol; 2018; 16(6):740-748. PubMed ID: 29046156
[TBL] [Abstract][Full Text] [Related]
17. Current insights into computer-aided immunotherapeutic design strategies.
Cai Z; Zhang G; Zhang X; Liu Y; Fu X
Int J Immunopathol Pharmacol; 2015 Sep; 28(3):278-85. PubMed ID: 26091813
[TBL] [Abstract][Full Text] [Related]
18. Computational approaches for drug discovery.
Hung CL; Chen CC
Drug Dev Res; 2014 Sep; 75(6):412-8. PubMed ID: 25195585
[TBL] [Abstract][Full Text] [Related]
19. Structure- and ligand-based drug design methods for the modeling of antimalarial agents: a review of updates from 2012 onwards.
Vyas VK; Bhati S; Patel S; Ghate M
J Biomol Struct Dyn; 2022; 40(20):10481-10506. PubMed ID: 34129805
[TBL] [Abstract][Full Text] [Related]
20. Pharmacophore-based virtual screening, 3D QSAR, Docking, ADMET, and MD simulation studies: An in silico perspective for the identification of new potential HDAC3 inhibitors.
Lanka G; Begum D; Banerjee S; Adhikari N; P Y; Ghosh B
Comput Biol Med; 2023 Nov; 166():107481. PubMed ID: 37741229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]